Vijay Kumar Prajapati
Vijay Kumar Prajapati
Assistant Professor, Central University of Rajasthan
Verified email at - Homepage
Cited by
Cited by
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use
S Sundar, A Singh, M Rai, VK Prajapati, AK Singh, B Ostyn, M Boelaert, ...
Clinical infectious diseases 55 (4), 543-550, 2012
Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection
M Ali, RK Pandey, N Khatoon, A Narula, A Mishra, VK Prajapati
Scientific reports 7 (1), 1-13, 2017
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
N Khatoon, RK Pandey, VK Prajapati
Scientific reports 7 (1), 1-12, 2017
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes
VK Prajapati, K Awasthi, S Gautam, TP Yadav, M Rai, ON Srivastava, ...
Journal of antimicrobial chemotherapy 66 (4), 874-879, 2011
Novel immunoinformatics approaches to design multi-epitope subunit vaccine for malaria by investigating anopheles salivary protein
RK Pandey, TK Bhatt, VK Prajapati
Scientific reports 8 (1), 1-11, 2018
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis
V Bhandari, A Kulshrestha, DK Deep, O Stark, VK Prajapati, V Ramesh, ...
PLoS neglected tropical diseases 6 (5), e1657, 2012
Antileishmanial activity of nano-amphotericin B deoxycholate
KD Manandhar, TP Yadav, VK Prajapati, S Kumar, M Rai, A Dube, ...
Journal of Antimicrobial Chemotherapy 62 (2), 376-380, 2008
Circulating MicroRNAs: potential and emerging biomarkers for diagnosis of human infectious diseases
P Verma, RK Pandey, P Prajapati, VK Prajapati
Frontiers in microbiology 7, 1274, 2016
Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells
R Mukhopadhyay, S Mukherjee, B Mukherjee, K Naskar, D Mondal, ...
International journal for parasitology 41 (13-14), 1311-1321, 2011
An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis
VK Prajapati, K Awasthi, TP Yadav, M Rai, ON Srivastava, S Sundar
Journal of Infectious Diseases 205 (2), 333-336, 2012
Racial disparities in prostate cancer: a molecular perspective
A Bhardwaj, SK Srivastava, MA Khan, VK Prajapati, S Singh, JE Carter, ...
Frontiers in bioscience (Landmark edition) 22, 772, 2017
Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection
RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, VK Prajapati
Vaccine 36 (17), 2262-2272, 2018
Molecular and immunological toxic effects of nanoparticles
RK Pandey, VK Prajapati
International journal of biological macromolecules 107, 1278-1293, 2018
Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India
P Srivastava, VK Prajapati, M Vanaerschot, G Van der Auwera, ...
Infection, Genetics and Evolution 10 (7), 1145-1150, 2010
Differential expression of miRNA regulates T cell differentiation and plasticity during visceral leishmaniasis infection
RK Pandey, S Sundar, VK Prajapati
Frontiers in microbiology 7, 206, 2016
Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic
P Srivastava, VK Prajapati, M Rai, S Sundar
Journal of clinical microbiology 49 (8), 3088-3091, 2011
Evaluation of Blood Agar Microtiter Plates for Culturing Leishmania Parasites To Titrate Parasite Burden in Spleen and Peripheral Blood of Patients with Visceralá…
R Maurya, S Mehrotra, VK Prajapati, S NylÚn, D Sacks, S Sundar
Journal of clinical microbiology 48 (5), 1932-1934, 2010
Molecular docking and in vitro antileishmanial evaluation of chromene-2-thione analogues
RK Verma, VK Prajapati, GK Verma, D Chakraborty, S Sundar, M Rai, ...
ACS medicinal chemistry letters 3 (3), 243-247, 2012
Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection
A Narula, RK Pandey, N Khatoon, A Mishra, VK Prajapati
Infection, Genetics and Evolution 61, 4-15, 2018
The system can't perform the operation now. Try again later.
Articles 1–20